市場調查報告書
商品編碼
1209793
全球牛奶礦物質濃縮物市場:到 2028 年的預測 - 按來源、鈣含量、粒度(微粉、標準粉)、應用和地區進行的全球分析Milk Mineral Concentrate Market Forecasts to 2028 - Global Analysis By Source, Calcium Content, Granularity (Micronized Powder and Standard Powder ), Application and Geography |
根據Stratistics MRC,2022年全球mimilk精礦市場規模將達到1097.9億美元,預計2028年將達到1611.1億美元,預測期內有望以CAGR增長在此期間為 6.6%。
Mimilk Mineral Concentrate 是一種使用專有分離技術獲得的天然牛奶礦物質。 牛奶礦物質濃縮物通常富含鈣、磷酸鹽和其他牛奶礦物質。 牛奶礦物質對人體健康至關重要,尤其是骨骼健康。 Milk Mineral Concentrate 是通過過濾乳清製成的,這是奶酪製作中的不同產品。 幾種分離方法用於分離乳清,然後將其乾燥並研磨成細粉。 含有大量的鈣、鉀、鹽等人體必需的礦物質,作為營養補充劑添加到嬰幼兒配方奶粉、營養食品、飲食品中。
根據骨骼健康和骨質疏鬆症基金會 (BHOF) 於 2021 年發表的一篇文章,大約有 1000 萬美國人患有骨質疏鬆症,其中約有 4400 萬人因骨量低而處於患骨質疏鬆症的高風險中。估計。
市場動態
驅動程序
骨骼相關疾病的患病率增加,尤其是在老年人中
隨著老年人口的增加,患病率也在增加。 多種因素,包括膳食鈣攝入量不足、自身免疫性疾病等潛在疾病,以及減少個體鈣吸收的藥物,都增加了全球鈣缺乏症的患病率。 人口缺鈣導致骨相關疾病的患病率增加,造成治療需求未得到滿足。 這些因素增加了對鈣強化食品和膳食補充劑的需求,以滿足鈣和其他礦物質的膳食攝入量。
抑製劑
消費者對素食主義的偏好上升
越來越多的消費者尋求更健康的生活方式,這推動了對傳統加工肉類產品的需求和偏好,同時減少了對乳製品的需求。 發達國家和新興國家越來越偏愛素食者的原因有很多。 此外,植物基替代品現在被認為是更有營養和更優質的牛奶替代品,導緻美國和英國等發達國家的乳製品和牛奶消費量下降。 這些因素可能會限制預測期內全球市場的增長。
機會
改變消費者對更有營養食品的偏好
在全球範圍內,健康意識的提高和與營養不良相關的疾病正在推動營養補充劑、強化飲料和飲食的使用增加。 同樣,更新的指南和政府對市場進入者產品質量一致性的更多承諾鼓勵這些公司開發和推出更廣泛用途的產品,□□例如腸道健康和免疫力。研究和活動正在變得活躍。 隨著消費者偏好轉向更有營養的食品,用於各種食品和飲料鈣強化的牛奶礦物質濃縮物的需求預計會增加。
威脅
價格變化
由於各種供需因素和政府法規,牛奶和乳製品的成本每週、每月都在波動。 另一方面,牛奶產量、泌乳持續時間和乾奶期已被證明受遺傳背景、環境、疾病、飲食、產犢年份和時間的影響。 品種、年齡、哺乳期、胎次和擠奶次數會影響生產性能,並且是由於重大市場限制導致牛奶價格不斷波動的主要原因。
COVID-19 的影響
在預測期內,COVID-19 的影響對市場增長產生了積極影響。 在 COVID-19 流行期間,對牛奶和其他乳製品的需求有所增加。 由於供應鍊和物流略有中斷,濃縮奶製造商的原材料和材料採購略有停滯。 加上公眾對牛奶及乳製品的需求增加,牛奶及乳製品的產量下降,導致原材料價格飆升。 由於這些因素,高附加值產品的銷量下降,導致銷售額增加。
20%-25% 的部分預計在預測期內將是最大的部分
由於礦物質缺乏症的患病率上升以及對該疾病和可能治療方法的認識不斷提高,預計 20% 至 25% 的細分市場將實現有利增長。 為了滿足對礦物濃縮物的需求,市場進入者(例如 Glanbia PLC. 和 Arla Foods Ingredients Group P/S)正專注於提高鈣等關鍵礦物質的濃度。 預計這些變量將在預測期內推動該細分市場的擴張。
嬰兒配方奶粉市場預計在預測期內實現最高複合年增長率
由於中國和日本等新興國家對新生兒和兒童礦物質缺乏的認識不斷提高,嬰兒配方奶粉市場預計在預測期內將以最快的複合年增長率增長。 臨床試驗的增加和監管框架的擴大,以開發和銷售富含營養分子的嬰兒配方奶粉,以解決營養水平下降的問題。,是促進這一細分市場增長的主要因素。
市場份額最高的地區
由於缺鈣疾病患病率增加等因素,亞太地區預計在預測期內將佔據最大的市場份額,尤其是在嬰兒和老年人中。 此外,旨在通過或更新有關嬰兒配方奶粉等強化食品的新立法的政府活動增加,預計也將推動該地區的市場。 此外,中國和日本等國家嬰兒配方奶粉消費量的增加促使市場進入者不斷提供礦物質含量更高的產品,從而導致整個預測期內嬰兒配方奶粉的增長。預計對奶粉的需求將增加。
複合年增長率最高的地區
由於美國和加拿大患有微量營養素缺乏症的患者數量不斷增加,預計北美在預測期內的複合年增長率最高。 消費者的健康意識越來越強,他們的身體活動正在迅速增加,需要運動和富含蛋白質的補充劑。 由於關鍵礦物質和微量營養素的消耗量下降,人們越來越關注健康問題,以及該地區人們對礦物質缺乏症的認識和認識不斷提高,這些都是推動北美市場上漲的部分原因。
主要發展
2022 年 6 月,Sachsenmilch Leppersdorf GmbH 與 FrieslandCampina DOMO 簽署協議,收購 5 個乳製品系列品牌和 3 個生產設施。
2022 年 3 月,Arla Foods Ingredients Group P/S 將推出兩款嬰兒營養新產品,旨在擴大其有機產品系列,以鞏固其在有機領域的市場地位。
2021 年 2 月,FrieslandCampina DOMO 宣布與 Cayuga Milk Ingredients 建立新的合作夥伴關係,生產 Refit 牛奶蛋白 MPI 90 和 MPC 85,以增加其產品組合。
本報告的內容
免費定制服務
訂閱此報告的客戶將免費獲得以下自定義選項之一。
According to Stratistics MRC, the Global Milk Mineral Concentrate Market is accounted for $109.79 billion in 2022 and is expected to reach $161.11 billion by 2028 growing at a CAGR of 6.6% during the forecast period. Milk mineral concentrate is a naturally occurring type of milk mineral obtained using a proprietary isolation technique. Milk mineral concentrates are generally high in calcium, phosphoric acid, and other milk minerals. Milk minerals are essential for human health, particularly for bone health. Milk mineral concentrations are made by filtering whey, a by-product of cheese manufacture. Several isolation procedures are used to fractionate the whey, which is subsequently dried and crushed into fine powders. These are high in calcium, potassium, salt, and other vital minerals and are used to supplement nutrition by adding them to infant formulae, nutritional foods, beverages, and other products.
According to an article published by Bone Health and Osteoporosis Foundation (BHOF) in 2021, it is estimated that around 10 million Americans have osteoporosis, and around 44 million are at high risk for its development due to low bone mass.
Market Dynamics:
Driver:
Growing prevalence of bone-related disorders especially among geriatric population
The prevalence is rising as the senior population grows. The global prevalence of calcium shortage is increasing due to a variety of factors, including inadequate calcium intake in the diet, underlying medical diseases such as autoimmune illnesses, and drugs that reduce calcium absorption in individuals. As a result of calcium insufficiency in the population, the prevalence of bone-related disease is increasing, producing an unmet need for therapy. These factors are increasing the need for calcium-fortified foods and dietary supplements to meet the required dietary intake of calcium and other minerals.
Restraint:
Growing inclination of consumers toward vegan food
The growing consumer preference for a healthy lifestyle is moving demand and preference away from traditionally processed meat products, which is simultaneously reducing demand for dairy products. Many reasons are contributing to a movement in population preference for vegan food consumption in industrialised and emerging countries. Furthermore, plant-based alternatives are now considered a more nutritious and superior choice of milk, leading in lower consumption of dairy milk and products in industrialised countries such as the United States, the United Kingdom, and others. These factors are expected to limit the global market's growth over the forecast period.
Opportunity:
Shifting consumer preference towards more nutritious food products
Globally, rising health consciousness and illnesses caused by a lack of nutrient consumption are driving an increase in the use of dietary supplements, fortified beverages, and meals. Similarly, increased government measures to update guidelines and conform to the quality of products created by market participants are encouraging these firms' research and activities to develop and launch products with a broader range of applications such as gut health and immunity, among others. As a result of consumer preferences shifting toward more nutritious food products, demand for milk mineral concentrate manufacturing for calcium fortification of various food products and beverages is predicted to increase.
Threat:
Price fluctuations
Milk and dairy product costs fluctuate on a weekly and monthly basis, depending on a range of supply and demand factors as well as government regulations. Milk production, lactation length, and dry period, on the other hand, have been shown to be affected by genetic background, environment, illnesses, food, year, and season of calving. Breed, age, lactation stage, parity, and milking frequency all have an impact on performance, which is the primary cause for the constant fluctuation of milk prices, as a result of these factors imposing significant constraints on the market.
COVID-19 Impact
During the predicted period, the COVID-19 influence on market growth was positive. During the COVID-19 epidemic, there was an increase in demand for milk and other dairy products. The procurement of raw materials and ingredients by milk mineral concentrate makers was hampered slightly due to minor interruptions in the supply chain and logistics. Higher raw material prices arose from the population's increased demand for milk and dairy products, along with decreasing production of milk and other products. These factors resulted in lower sales volume of products with higher ASPs, resulting in higher revenues.
The 20% to 25% segment is expected to be the largest during the forecast period
The 20% to 25% segment is estimated to have a lucrative growth, due to the increasing number of people with mineral deficiencies and growing awareness of the illnesses and possible treatment options. To address the demand for mineral concentrates, market participants such as Glanbia PLC., Arla Foods Ingredients Group P/S, and others are focusing on boosting the concentration of key minerals such as calcium. During the projection period, these variables are expected to boost segmental expansion.
The infant formula segment is expected to have the highest CAGR during the forecast period
The infant formula segment is anticipated to witness the fastest CAGR growth during the forecast period, due to the increased awareness of mineral inadequacies among newborns and children in emerging countries such as China, Japan, and others. Another key element contributing to the segment's growth is the increasing number of clinical trials to develop and launch infant formulae with added nutritious molecules to address the impaired nutrition level, as well as the expanding regulatory framework.
Region with highest share:
Asia Pacific is projected to hold the largest market share during the forecast period owing to the factors such as the increased prevalence of calcium deficient illnesses in the population, particularly among babies and the elderly. Furthermore, rising government activities to adopt and update new laws for fortified food products such as infant formulae are expected to drive the market in the region. And also, rising infant formula consumption in countries such as China, Japan, and others is driving market participants to offer products with continual improvements in mineral content, which is expected to increase demand for infant formulae throughout the forecast period.
Region with highest CAGR:
North America is projected to have the highest CAGR over the forecast period, owing to increasing patient population suffering from micronutrient deficiency disorders in the U.S. and Canada. Customers are becoming more health concerned, and there is a quick increase in exercise activities, which leads to sports and protein-rich supplements. Rising health concerns due to lesser consumption of vital minerals and micronutrients, increased awareness and identification of mineral deficiency disorders among the region's population are some of the reasons leading to the market's rise in North America.
Key players in the market
Some of the key players profiled in the Milk Mineral Concentrate Market include Arla Foods Ingredients Group P/S, ARMOR PROTEINES, Fonterra Co-Operative Group Limited, FrieslandCampina DOMO, MILEI GmbH, Sachsenmilch Leppersdorf GmbH, Glanbia PLC, Whiteoakmills, Lactalis Ingredients, Food Ingredient Technology Co., Ltd., MG Ingredients, Draco Ingredients, Donaghys
Key Developments:
In June 2022, Sachsenmilch Leppersdorf GmbH entered into an agreement with FrieslandCampina DOMO to take over five brands of dairy product range and three production facilities.
In March 2022, Arla Foods Ingredients Group P/S launches two new products for early life nutrition with an aim to expand its organic offering to strengthen its position in the market in the organic sector.
In February 2021, FrieslandCampina DOMO announced a new partnership with Cayuga Milk Ingredients for the production of its Refit milk proteins MPI 90 and MPC 85 with an aim to increase its product portfolio.
Sources Covered:
Calcium Contents Covered:
Granularities Covered:
Applications Covered:
Regions Covered:
What our report offers:
Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options: